ADVERTISEMENT

 

Press Releases

 

23

Jan

2023

Aspirin may be just as good as blood thinner injections for hospitalized fracture patients

Author: Anonym

Findings from a new clinical trial found that OTC aspirin can be just as effective as an injectable blood thinner, low-molecular-weight heparin to prevent life-threatening blood clots for patients hospitalized with fractures.

Comments (0)
Number of views (18483)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

20

Jan

2023

CDC examines top reasons adults didn’t get bivalent COVID-19 booster

Author: Anonym

A new CDC report finds that low vaccination uptake for the COVID-19 bivalent vaccine was due to lack of awareness about eligibility status as well as overconfidence in immunity against the virus.

Comments (0)
Number of views (12736)
Article rating: 3.0
Read more

Categories: APhA News

Tags: APhA News

13

Jan

2023

CDC reports new drop in child vaccination rates

CDC said last week that disruptions in health care access during the COVID-19 pandemic contributed to declining rates of routine immunizations among young children. In a new report, the agency said that uptake of state-mandated vaccines dropped somewhat in 2021–22 for kindergarteners.

Comments (0)
Number of views (18819)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

13

Jan

2023

Pharmacists offer accessible treatment for patients with opioid use disorder, says study

Author: Anonym

Findings from a new study published in NEJM suggest that pharmacists can safely and effectively start patients with opioid use disorder on buprenorphine.

Comments (0)
Number of views (18962)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

5

Jan

2023

What’s the longer-term effect of treatment for critically ill patients with COVID-19?

Author: Anonym

Researchers of a new study published in JAMA found that among critically ill patients with COVID-19, there was a high likelihood of improved 180-day mortality among patients treated with IL-6 receptor antagonists and antiplatelet agents.

Comments (0)
Number of views (12998)
Article rating: 3.0
Read more

Categories: APhA News

Tags: APhA News

RSS
First2526272830323334Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT